文献速递美容整形

面部美容A型肉毒毒素注射并发症:英国MHRA登记分析与文献综述

Complications of facial cosmetic botulinum toxin A injection: analysis of the UK Medicines & Healthcare Products Regulatory Agency registry and literature review.
PubMed 文献 · J Plast Reconstr Aesthet Surg · 2021-06-17

研究分析英国MHRA 1991至2020年面部美容BoNT-A注射不良事件报告,并与文献荟萃分析比较。MHRA仅报告188例不良事件,而30项研究共17352次注射的并发症率为16%(95%CI 8%-25%),提示MHRA可能低估不良事件,对患者安全和知情同意有影响。

要点

  • MHRA登记的面部美容BoNT-A不良事件仅188例,远低于文献荟萃分析的并发症率。
  • 文献荟萃30项研究17352次注射,总并发症率16%(95%CI 8%-25%)。
  • 常见不良事件:瘀斑5%、头痛3%、面部轻瘫2%。

核心结论

  • MHRA登记的面部美容BoNT-A不良事件率显著低于国际文献荟萃分析估计,提示MHRA可能低估不良事件,对患者安全和知情同意有影响,英国或需立法改进报告。

研究设计与样本

  • 通过信息自由请求获取MHRA 1991至2020年BoNT-A并发症记录,仅纳入适应症为面部美容的病例进行分析。
  • 同时检索文献中面部美容BoNT-A注射不良事件,并进行并发症率的统计荟萃分析。

主要发现

  • MHRA共报告188例美容BoNT-A注射不良事件。
  • 文献检索纳入30项研究共17352次注射,并发症率为16%(95%CI 8%-25%)。
  • 常见不良事件包括局部皮肤反应如瘀斑发生率5%(95%CI 3%-7%)、头痛3%(95%CI 1%-5%)、面部轻瘫2%(95%CI 1%-3%)。

临床怎么用

  • 临床应知晓文献报道的面部美容BoNT-A并发症率(16%)远高于MHRA登记数据,知情同意时应充分告知常见不良事件如瘀斑、头痛和面部轻瘫。

局限性

  • MHRA数据基于自愿报告,可能存在漏报,导致不良事件被低估;文献荟萃分析纳入的研究间可能存在异质性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Botulinum toxin A (BoNT-A) injection is one of the most frequently undertaken procedures in aesthetic medicine. The Medicines & Healthcare products Regulatory Agency (MHRA) is the government body in the United Kingdom (UK) mandated to ensure that the provision and administration of medicines is safe. We analyzed adverse events of facial cosmetic BoNT-A injections reported to the MHRA and assessed whether the incidence of reported adverse events in this government registry is comparable to published retrospective and prospective studies. METHODS: A freedom of information (FOI) request was submitted to the MHRA to obtain recorded complications of BoNT- A. Complications reported to the MHRA between 1991 and 2020 were analyzed. Only cases with BoNT-A where the indication was specified as for facial cosmetics were included in the analysis. Additionally, the literature was reviewed on adverse events of facial cosmetic BoNT- A injections, and a statistical meta-analysis of complication rates was carried out. RESULTS: A total of 188 adverse events of aesthetic BoNT-A injections were reported to the MHRA. The literature search resulted in 30 studies and a total of 17,352 injection sessions, where the complication rate was 16% (95% CI = 8% to 25%). Frequent adverse events included localized skin reactions such as bruising with an incidence of 5% (95% CI = 3% to 7%), headache in 3% (95% CI = from 1% to 5% ), and facial paresis in 2% (95% CI = 1% to 3%) of injection sessions. CONCLUSIONS: This is the first paper to obtain and evaluate data on adverse events of BoNT-A from the MHRA. An estimate of the likely complication rate of aesthetic BoNT-A in the UK, according to the MHRA database, is significantly lower than the rate recorded from our meta-analysis of the international literature. This suggests that the MHRA may be underestimating the adverse events of aesthetic BoNT-A treatment, which would have implications for patient safety and informed consent. Therefore, legislative changes may be required to ensure more robust reporting of aesthetic BoNT-A in the UK.

来源:J Plast Reconstr Aesthet Surg,查看原文。版权归原作者所有。

引用

  1. Zargaran D, Zoller FE, Zargaran A, et al. Complications of facial cosmetic botulinum toxin A injection: analysis of the UK Medicines & Healthcare Products Regulatory Agency registry and literature review. J Plast Reconstr Aesthet Surg. 2021. PMID: 34456155. doi:10.1016/j.bjps.2021.05.074

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。